RTTNews | Apr 9, 2021 07:02AM EDT

07:02 Friday, April 9, 2021 (RTTNews) - RedHill Biopharma's Phase 2/3 COVID-19 Study Of Opaganib Gets Unanimous Recommendation To Continue

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved